JOURNAL OF COSMETIC SCIENCE 560 size may infl uence product quality (81). Another concern is the cost and variable purity of phospholipids, which may cause trouble in massive production (12). In comparison, niosomes are more stable and the low cost of materials makes them suitable for industry manufacture. Stability is also a concern when SLN and micro-/nanoemulsions are applied to cosmetic and cosmeceutical products. In conclusion, a desired carrier system for cosmetic and cosmeceutical use requires release- control effects on active ingredients so that they remain at a constant level in the skin in order to preserve function for a period of time without repeated application of the prod- uct. The carrier system should also facilitate the ingredient penetration into certain layers of the skin, i.e., into vital epidermis and dermis but not into the blood circulation. The desired carrier system loading with the active ingredient should have a reasonably long shelf life, higher biocompatibility, and lower irritation properties. How to utilize carrier systems for each individual active ingredient and to overcome their limitations are con- cerns of further research. REFERENCES (1) History of cosmetics. http://en.wikipedia.org/wiki/History_of_cosmetics (20/2/2011). (2) Market Trends: The U.S. Cosmeceuticals and Anti-Aging Products Market. Packaged Facts: A Division of Market. http://www.packagedfacts.com/ Internet (11/6/2006). (3) Food Drug and Cosmetic Act, sec.201(i). Chapters I and II of the Federal Food, Drug, and Cosmetic Act. (4) B. S. Oricha, Cosmeceuticals: A review, Afr. J. Pharm. Pharmacol., 4(4), 127–129 (2010). (5) C. M. Choi and D. S. Berson, Cosmeceuticals, Sem. Cut. Med. Surg., 25, 163–168 (2006). (6) M. E. Aulton, Aulton’s Pharmaceutics: The Design and Manufacture of Medicines (Churchill Livingstone, Elsevier, 2007), pp. 565–566. (7) R. J. Scheuplein, Mechanism of percutaneous absorption: Transient diffusion and the relative impor- tance of various routes of skin penetration, Invest. Dermatol., 48(1), 79–88 (1967). (8) C. Sinico and A. M. Fadda, Vesicular carriers for dermal drug delivery, Drug Delivery, 8, 813–825 (2009). (9) G. Cevc, Transfersomes, liposomes and other lipid suspensions on the skin: Permeation enhancement, vesicle penetration, and transdermal drug delivery, Crit. Rev. Therapeut. Drug Carrier Syst., 13, 257–388 (1996). (10) T. Ogiso, N. Niinaka, and M. Iwaki, Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. [Erratum appears in J. Pharm. Sci., May 1996, 85(5), 546]. J. Pharmaceut. Sci., 85, 57–64 (1996). (11) J. De Leeuw, H. De Vijlder, P. Bjerring, and H. Neumann, Liposomes in dermatology today, J. Eur. Acad. Dermatol. Venereol., 23, 505–516 (2009). (12) B. Vora, A. J. Khopade, and N. K. Jain, Proniosome based transdermal delivery of levonorgestrel for effective contraception, J. Control. Release, 54, 149–156 (1998). (13) A. D. Bangham and D. Papahadjopoulos, Biophysical properties of phospholipids. I. Interaction of phosphatidylserine monolayers with metal ions, Biochim. Biophys. Acta, 126, 181–184 (1966). (14) M. Mezei and V. Gulasekharam, Liposomes—A selective drug delivery system for the topical route of administration. I. Lotion dosage form., Life Sciences, 26, 1473–1477 (1980). (15) L. Lesoin, O. Boutin, C. Crampon, and E. Badens, CO2/water/surfactant ternary systems and liposome formation using supercritical CO2: A review, Colloids Surf. A, 371, 1–14 (2011). (16) G. M. Maghraby, A. C. William, and B. W. Barry, Can drug-bearing liposomes penetrate intact skin? J. Pharm. Pharmaca., 58(4), 415–429 (2006). (17) G. Cevc, A. Schatzlein, and H. Richardsen, Ultradeformable lipid vesicles can penetrate skin and other semi-permeable membrane barriers unfragmented. Evidence from double label CLSM experiments and direct size measurement, Biochim. Biophys. Acta, 1564, 21–30 (2002). (18) H. Hofl and, J. Bouwstra, F. Spiesb, et al, Interactions between nonionic surfactant vesicles and human stratum corneum in vitro, J. Liposome Res., 5(2), 241–263 (1995).

ADVANCED CARRIER SYSTEMS 561 (19) W. Abraham and D. T. Downing, Interaction between corneocytes and stratum corneum lipid lipo- somes in vitro, Biochim. Biophys. Acta, 1021(2), 119–125 (1990). (20) M. Kirjavainen, A. Uritt, and I. Jaaskelainen, Interaction of liposomes with human skin in vitro—The infl uence of lipid composition and structure, Biochim. Biophys. Acta, 1304(3), 179–189 (1996). (21) M. H. Schmid and H. C. Korting, Therapeutic progress with topical liposome drugs for skin disease, Adv. Drug. Deliv. Rev., 18, 355–342 (1996). (22) G. Betz, A. Aeppli, N. Menshutina, and H. Leuenberger, In vivo comparison of various liposome for- mulations for cosmetic application, Int. J. Pharmaceuti., 296, 44–54 (2005). (23) N. Moussaoui, M. Cansell, and A. Denizot, Marinosomes®, marine lipid-based liposomes: Physical characterization and potential application in cosmetics, Ibid., 242, 361–365 (2002). (24) T. Makoto, K. Dai, A. Yonathan, T. Kensaku, and W. Koji, Liposomes encapsulating Aloe vera leaf gel extract signifi cantly enhance proliferation and collagen synthesis in human skin cell lines. J. Oleo Sci., 58, 643–650 (2009). (25) Delivery System Handbook for Personal Care and Cosmetic Products Technology, Applications, and Formulations (William Andrew Publishers, New York, 2005), pp. 297. (26) C. Sinico et al. Liposomes as carriers for dermal delivery of tretinoin: In vitro evaluation of drug perme- ation and vesicle–skin interaction., J. Control. Release, 103, 123–136 (2005). (27) A. Semalty, M. Semalty, M. S. Rawat, and F. Franceschi, Supramolecular phospholipids–polyphenolics interaction: The PHYTOSOME® strategy to improve the bioavailability of phytochemicals, Fitoterapia, 81, 306–314 (2010). (28) J.-Y. Fang, T.-L. Hwang, and C.-L. Fang,. Enhancement of the transdermal delivery of catechins by li- posomes incorporating anionic surfactants and ethanol, Int. J. Pharmaceut., 310, 131–138 (2006). (29) R. M. Handjani-Vila, A. Ribier, B. Rondot, and G. Vanlerberghie. Dispersions of lamellar phases of non-ionic lipids in cosmetic products, Int. J. Cosmet. Sci., 1, 303–314 (1979). (30) A. Azeem, M. K. Anwer, and S. Talegaonkar, Niosomes in sustained and targeted drug delivery: Some recent advances, J. Drug Targeting, 17, 671–689 (2009). (31) I. F. Uchegbu and S. P. Vyas, Non-ionic surfactant based vesicles (niosomes) in drug delivery, Int. J. Pharmaceut., 172, 33–70 (2008). (32) M. J. Choi and H. I. Maibach. Liposomes and niosomes as topical drug delivery systems, Skin Pharmacol. Physiol., 18, 209–219 (2005). (33) A. Azeem, N. Jain, and Z. Iqbal. Feasibility of proniosomes based transdermal delivery of frusemide: Formulation optimization and pharmacotechnical evaluation, Pharm. Dev. Technol., 1, 155–163 (2008). (34) S. A. Wissing, and R. H. Müller, Solid lipid nanoparticles as carrier for sunscreens: In vitro release and in vivo skin penetration, J. Control. Release, 81, 225–233 (2002). (35) M. Manconi, C. Sinico, D. Valenti, et al., Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin, Int. J. Pharmaceut., 311, 11–19 (2006). (36) C. Hu and D. G. Rhodes, Proniosomes: A novel drug carrier preparation, Ibid., 206, 110–122 (2000). (37) Y. Wang, B. Wang, W. Qiao, and T. Yin. A novel controlled release drug delivery system for multiple drugs based on electrospun nanofi bers containing nanoparticles, J. Pharmacaeut. Sci., 99(12), 4805–4811 (2010). (38) S. Scheler, M. Kitzan, and A. Fahr, Cellular uptake and degradation behaviour of biodegradable poly(ethylene glycol-graft-methyl methacrylate) nanoparticles crosslinked with dimethacryloyl hydrox- ylamine, Int. J. Pharmaceut., 403(1–2), 207–218 (2010). (39) R. Schueller and P. Romanowski, Emerging Technoligies and the Future of Cosmetic Science. http://www. specialchem4cosmetics.com/services/articles.aspx?id=957&page=Nanomaterials. (40) S. Torrado, J. J. Torrado, and R. Cadórniga, Topical application of albumin microspheres containing vitamin A drug release and availability, Int. J. Pharmaceut., 86, 147–152 (1992). (41) Y. Yoshihisa, A. Honda, Q. L. Zhao, et al. Protective effects of platinum nanoparticles against UV-light- induced epidermal infl ammation, Exper. Dermatol., 19, 1000–1006 (2010). (42) S. Lu et al. Concentration effect of gold nanoparticles on proliferation of keratinocytes, Colloids Surf., B, in press. (43) S. Kokura et al., Silver nanoparticles as a safe preservative for use in cosmetics, Nanomed. Nanotechnol. Biol. Med., 6, 570–574 (2010). (44) G. J. Nohynek, J. Lademann, et al. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety, Criti. Rev. Toxicol., 37(3), 251–277 (2007). (45) R. H. Müller, M. Radtke, and S. A. Wissing, Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations, Adv. Drug Deliv. Rev., 54, S131–S155 (2002).